Zynerba Pharmaceuticals Inc.
Rank 51
About
Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.
$9.87
USD
17.43%
Market cap
$207,965,074
Total volume
$39,402,403
Shares outstanding
21,069,996
Rank 51
About
Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
ZYNE |
$39,402,403
|
100% |
$9.87
|
Chart